Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
about
Proteomic and biomarker studies and neurological complications of pediatric sickle cell diseaseNeuropsychology in Cameroon: first normative data for cognitive tests among school-aged children.Risk and resilience factors for grade retention in youth with sickle cell disease.Cognitive training programs for childhood cancer patients and survivors: A critical review and future directions.Parental problem-solving abilities and the association of sickle cell disease complications with health-related quality of life for school-age children.Mean Platelet Volume can Predict Cerebrovascular Events in Patients with Sickle Cell Anemia.Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate.Know thyself: real-world behavioral correlates of self-appraisal accuracy.Hemodynamic responses to visual stimulation in children with sickle cell anemia.Risk Factors for Attention and Behavioral Issues in Pediatric Sickle Cell Disease.School Performance and Disease Interference in Adolescents with Sickle Cell Disease.Comprehensive neuropsychological evaluation of children and adolescents with sickle cell anemia: a hospital-based sample.Cerebral blood flow velocity and language functioning in pediatric sickle cell disease.The use of stimulant medication to treat neurocognitive deficits in patients with pediatric cancer, traumatic brain injury, and sickle cell disease: a review.Hypoxia and inflammation in children with sickle cell disease: implications for hippocampal functioning and episodic memory.Psychiatric problems in children and adolescents with sickle cell disease, based on parent and teacher reports.Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin.Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.Neurocognitive deficits in children with sickle cell disease: a comprehensive profile.Working Memory in Children With Neurocognitive Effects From Sickle Cell Disease: Contributions of the Central Executive and Processing Speed.Psychiatric diagnosis in adolescents with sickle cell disease: a preliminary report.Neurocognitive deficits in children with sickle cell disease are associated with the severity of anemia.Special series introduction: NIH EXAMINER and the assessment of executive functioning.White matter damage in asymptomatic patients with sickle cell anemia: screening with diffusion tensor imaging.Family Functioning, Medical Self-Management, and Health Outcomes Among School-Aged Children With Sickle Cell Disease: A Mediation Model.Developmental Screening in Pediatric Sickle Cell Disease: Disease-Related Risk and Screening Outcomes in 4 Year Olds.Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trial.Brain morphometric analysis predicts decline of intelligence quotient in children with sickle cell disease: A preliminary study.Event-based prospective memory in children with sickle cell disease: effect of cue distinctiveness.Differences in Activation and Deactivation in Children with Sickle Cell Disease Compared with Demographically Matched Controls.Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children.Cognitive and attentional functioning in adolescents and young adults with Tetralogy of Fallot and d-transposition of the great arteries.Performance validity testing in a clinical sample of adults with sickle cell disease.Sheehan's syndrome and sickle cell disease: the story of Natasha.EXAMINER executive function battery and neurologic morbidity in pediatric sickle cell disease.Executive function performance on the children's kitchen task assessment with children with sickle cell disease and matched controls.Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.Prevention of Morbidity in sickle cell disease--qualitative outcomes, pain and quality of life in a randomised cross-over pilot trial of overnight supplementary oxygen and auto-adjusting continuous positive airways pressure (POMS2a): study protocol f
P2860
Q27027066-E0AF9CA4-5C67-4C71-AB96-6712658B950CQ33430869-8B50E8AF-3F2C-435F-A2EA-7A0A2B7891ABQ33608149-0AC1ACA4-8306-4F49-80E5-75DBBA25DBF8Q34044232-4C0C83EC-AAD5-4F9A-B5F4-D377538087DEQ35039900-62FE7FF9-1C1B-4FD5-8E7A-9951577F1526Q35277610-C3A6CF48-D1AF-41B7-A5D2-2CE650953FF9Q35871766-9B614A58-3872-424E-8EA0-C69BBB67BEFAQ36650293-2323DF81-475F-4D87-A59F-BCE2F2B92AE4Q36749653-74656830-C4B2-4473-9F67-451460C0628FQ37146085-057F6A0D-FACD-4460-BA00-1EEA07F2B2D5Q37190705-F102E4F3-5E66-4C7F-8147-1FD5EBB2D6E9Q37683309-B567ED10-6DCB-4CF1-B220-4F41B1E398A0Q37686573-531691BD-0467-40FF-A48D-15ADE3B053F8Q38055294-EED97051-B7F7-4B7C-8156-76C14FCDF531Q38205407-A34BE2E1-D99C-479B-805F-202F707AFF13Q38753980-98D5BC4A-9009-4F3F-806C-EFEAAAAAACCFQ39233975-C1AEEDCA-74AF-430F-B1E4-0E9B6AC230F2Q39375218-3870B188-9145-4175-8D83-B1625B4993BFQ39776180-6E18E907-1DF4-4B7A-A2FC-22B4B56E4420Q42358449-E5AB033B-2D3F-4BDA-8488-ACAEDEF1BE92Q44053565-B410FBEB-7EB1-4B75-A1A0-041780A3874EQ44323071-BFC769E6-9C6A-4150-BF1F-B5E69FCCA230Q46123188-BF80F3BA-33B4-48A9-9D9D-AA34CA104855Q46329350-D5514A68-111E-42BF-B9CA-316968563C5AQ47239365-78334C64-5546-4AB7-8B93-48EE3F651E47Q47294485-404CB05C-BEF0-45D9-B5B2-66222A7AB21EQ47642462-74432729-5E8C-435E-88E9-519E5DA114DCQ47936167-DD107E77-F2F5-499A-B54B-DA765936521BQ48222294-4DAE3771-D04C-4110-8C4A-9A116A1EDA2FQ48276538-42C6CB80-CBC5-4402-B038-DD31D18669D4Q48771981-A2255B00-9029-437C-8498-8FEEEEC7F54BQ50560240-A7656E69-AE3C-46ED-A726-D068E262A92BQ50578678-D3C4D00E-4EBB-4646-9A01-E183102128B4Q50611255-ED0728BD-60A5-4D3D-89A7-B30107297B8CQ50706842-2888ABC4-2AEE-4146-AADE-E1DE62EF1CEAQ51004065-A2838BEB-B51A-4B01-B78A-8BCE9D9B583FQ55427971-45FAB8BF-E67A-4F1B-9EDE-F2270723FB3DQ58319619-C266FBAB-2F7F-40D6-A3AC-5CFE89CE332C
P2860
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@ast
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@en
type
label
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@ast
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@en
prefLabel
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@ast
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@en
P2093
P2860
P1476
Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature.
@en
P2093
Adrienne L Williamson
Allison S Margulies
Courtney L Dirksen
Leslie D Berkelhammer
Rebecca A Prengler
Stacy D Sanford
William G Sharp
P2860
P304
P356
10.1080/09297040600800956
P577
2007-03-01T00:00:00Z